Trial reportPain research & management2026
Efficacy of Low-Dose Intravenous Ketamine With Spinal Anesthesia for Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Clinical Trial.
Trial report in Pain research & management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of Low-Dose Intravenous Ketamine With Spinal Anesthesia for Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Clinical Trial.Pain research & management · 2026Trial
- Early recovery patterns differ between medially congruent and posterior-stabilized total knee arthroplasty, with comparable 2-year outcomes: A triple-blinded randomized clinical trial.Journal of experimental orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficacy of low-dose intravenous (IV) ketamine as an adjunct analgesic to spinal anesthesia in total knee arthroplasty (TKA) remains uncertain. This study aims to assess ketamine's impact on postoperative pain level and opioid consumption.
methodsIn a randomized, triple-blind, placebo-controlled trial conducted at Shariati Hospital, Tehran, Iran, 65 patients undergoing unilateral TKA were assigned to receive either 0.5 mg/kg IV ketamine or saline. The primary outcome was cumulative opioid consumption in the first 24 h. Secondary outcomes were visual analog scale (VAS) pain scores at 2, 6, 12, and 24 h and at 2 and 6 weeks, knee range of motion at discharge, operative time, length of stay, and adverse effects.
resultsMedian 0- to 24-h opioid use was similar (ketamine 10 [range 10-17.5] vs. placebo 10 [range 10-15] morphine milligram equivalents [MME]; p = 1.00). VAS scores were numerically lower with ketamine at all time points, but no comparison remained significant after adjustment for multiple comparisons, and there was no time × treatment interaction. No significant differences were observed in other secondary outcomes, including knee flexion and extension, operative time, and length of stay. Side effects were minimal and comparable between groups.
conclusionsLow-dose IV ketamine shows no measurable analgesic benefits in the long term, and it does not significantly reduce pain or opioid use after TKA within a multimodal pain protocol. Further research is needed to explore various analgesia strategies and follow-up durations to optimize pain management.
trial registrationIranian Registry of Clinical Trials: IRCT20220315054298N1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.